Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of S-citalopram, citalopram, and R-citalopram on the firing patterns of dopamine neurons in the ventral tegmental area, N-methyl-D-aspartate receptor-mediated transmission in the medial prefrontal cortex and cognitive function in the rat.
Schilström B, Konradsson-Geuken A, Ivanov V, Gertow J, Feltmann K, Marcus MM, Jardemark K, Svensson TH. Schilström B, et al. Synapse. 2011 May;65(5):357-67. doi: 10.1002/syn.20853. Epub 2010 Sep 24. Synapse. 2011. PMID: 20730799
Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the rat.
Björkholm C, Frånberg O, Malmerfelt A, Marcus MM, Konradsson-Geuken Å, Schilström B, Jardemark K, Svensson TH. Björkholm C, et al. Int J Neuropsychopharmacol. 2014 Oct 31;18(3):pyu068. doi: 10.1093/ijnp/pyu068. Int J Neuropsychopharmacol. 2014. PMID: 25522408 Free PMC article.
Adjunctive alpha2-adrenoceptor blockade enhances the antipsychotic-like effect of risperidone and facilitates cortical dopaminergic and glutamatergic, NMDA receptor-mediated transmission.
Marcus MM, Wiker C, Frånberg O, Konradsson-Geuken A, Langlois X, Jardemark K, Svensson TH. Marcus MM, et al. Int J Neuropsychopharmacol. 2010 Aug;13(7):891-903. doi: 10.1017/S1461145709990794. Epub 2009 Oct 19. Int J Neuropsychopharmacol. 2010. PMID: 19835668 Free article.
Deuterium-substituted L-DOPA displays increased behavioral potency and dopamine output in an animal model of Parkinson's disease: comparison with the effects produced by L-DOPA and an MAO-B inhibitor.
Malmlöf T, Feltmann K, Konradsson-Geuken Å, Schneider F, Alken RG, Svensson TH, Schilström B. Malmlöf T, et al. J Neural Transm (Vienna). 2015 Feb;122(2):259-72. doi: 10.1007/s00702-014-1247-6. Epub 2014 Jun 7. J Neural Transm (Vienna). 2015. PMID: 24906468
28 results